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Abstract
Background: Discovery of new medicinal agents from natural sources has largely been an
adventitious process based on screening of plant and microbial extracts combined with bioassay-
guided identification and natural product structure elucidation. Increasingly rapid and more cost-
effective genome sequencing technologies coupled with advanced computational power have
converged to transform this trend toward a more rational and predictive pursuit.
Results: We have developed a rapid method of scanning genome sequences for multiple
polyketide, nonribosomal peptide, and mixed combination natural products with output in a text
format that can be readily converted to two and three dimensional structures using conventional
software. Our open-source and web-based program can assemble various small molecules
composed of twenty standard amino acids and twenty two other chain-elongation intermediates
used in nonribosomal peptide systems, and four acyl-CoA extender units incorporated into
polyketides by reading a hidden Markov model of DNA. This process evaluates and selects the
substrate specificities along the assembly line of nonribosomal synthetases and modular polyketide
synthases.
Conclusion: Using this approach we have predicted the structures of natural products from a
diverse range of bacteria based on a limited number of signature sequences. In accelerating direct
DNA to metabolomic analysis, this method bridges the interface between chemists and biologists
and enables rapid scanning for compounds with potential therapeutic value.
Background
Many of the pharmaceuticals currently in clinical use have
natural product origins, illustrating the effectiveness of
compounds found in nature as antibiotic, anticancer, cho-
lesterol-lowering, antiparasitic and anti-fungal agents [1].
Testing for therapeutic activities remains conceptually
similar compared to the time of the discovery of penicillin
by Alexander Fleming. Scientists today still approach
identification of medicinal compounds by screening
chemicals for their ability to inhibit cellular growth. This
was a landmark step for science compared to using medi-
cines passed down through collective human experience,
but one from which we have not yet significantly
advanced [2].
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BMC Bioinformatics 2009, 10:185 http://www.biomedcentral.com/1471-2105/10/185The arrival of a powerful graphic user interface (GUI) in
the mid 1990s coincided with the first whole genome
sequence of the microorganism Haemophilus influenza [3].
This synergy of computational technology and molecular
biology was the beginning of whole genome analysis aid-
ing drug discovery by searching for robust protein targets.
Genome scanning was subsequently recognized as a
means of discovering useful secondary metabolites such
as nonribosomal peptides (NRPs), polyketides (PKs), and
terpenoids [4].
In analysis of secondary metabolism, computing abilities
such as multiple sequence alignment and crystallographic
analysis tools enable researchers to elucidate the functions
and characteristics of key enzymes involved in assembly
and tailoring of natural products including nonribosomal
peptide synthetases (NRPSs) and polyketide synthases
(PKSs). NRPs and PKs have long been utilized by bacteria
for cellular defense and offense against competitors [5].
They are prolific in nature and generate many of the anti-
biotics used clinically such as penicillin, erythromycin,
vancomycin, and daptomycin, among numerous others
[6]. Their ability to target important biomolecules high-
lights their significance in the central scheme of cellular
metabolism.
PKSs select simple acyl-CoAs and other extender units
with an acyltransferase (AT) domain, catalyze linkage of
the activated acyl chain onto a thiolation (T) domain, and
decarboxylate and condense the extender units using a
ketosynthase (KS) domain. Similarly, NRPSs bind and
activate amino acids and other carboxylic acids through
adenylation (A) and thiolation (T) domains and link
them together with a condensation (C) domain to create
a linear proteinogenic molecule that is either cleaved to
release a linear or cyclized molecule through the action of
a thioesterase (TE) [7], or in a few other cases, a reductase
(RE) domain [8]. Each KS, AT, and T domain or C, A, and
T domain for the PKSs and NRPSs, respectively, represent
the core of one module. Most of these systems have mul-
tiple modules that each catalyzes the binding and activa-
tion of an acyl-CoA or amino acid extender unit [9].
A and AT domains are considered the gatekeepers of mon-
omer selection of the starter and extender units that are
essential for NRP and PK biosynthesis. Signature amino
acid motifs determine which A or AT domain are likely to
activate a particular monomer, similar in concept to how
key residues, termed anticodons, in tRNAs determine
which cognate amino acid it binds [10]. This stored spe-
cificity from signature residues in a linear protein
sequence may be considered a hidden Markov model
(HMM) [11]. Much like how multiple tRNAs may bind to
the same amino acid, the NRPS A and PKS AT domain
amino acid binding sequence is degenerate, such that
multiple signature sequences can code for binding of the
NRPS or PKS domain to the same amino acid or
polyketide subunit, respectively. Multiple modifying
domains including those for methylation, oxidation,
epimerization, and reduction may sculpt the molecule
into a highly functionalized structure. A NRPS, PKS, or
hybrid NRPS-PKS enzymatic assembly-line can generate
an immense chemical library that is multiplied further by
enzymes within the natural product cluster to structurally
modify a NRP, PK, or mixed NRP-PK molecule after its
assembly through reactions such as hydroxylation, glyco-
sylation, cyclization, and halogenation [12].
The development of common letter coding for molecules,
namely the Simplified Molecular Input Line Entry Specifi-
cation (SMILES), has aided in organizing chemical struc-
tures within various vast chemical databases such as Zinc,
NCBI, and PubChem [13]. In an effort to access the power
of both genetic and chemical systems, we have developed
a framework to link NCBI and other genomic repositories
with chemical databases. Several programs have been
developed to recognize the signature sequence of NRPS
and PKS activating domains that enable limited genome
mining [14,15]. A recently published software program
named ClustScan produces SMILES from scanning NRPS/
PKS clusters. ClustScan, however, predicts only the basic
linear and cyclical conformations of a NRPS/PKS natural
product [16]. The new program described in this report,
NP.searcher, identifies and decodes DNA of potential nat-
ural product clusters and outputs multiple predictions for
structural assembly encoded by a PKS, NRPS, or hybrid
NRPS-PKS cluster, providing within seconds SMILES relat-
ing to the secondary metabolic products of a genome.
NP.searcher is complementary in this aspect to ClustScan
as it focuses on the combinatorial prediction of multiple
unique structures that may emerge from a cluster. ClustS-
can is focused primarily on PKS prediction and stereo-
chemistry of PK products. In contrast, NP.searcher was
originally developed to predict NRPs and further
expanded to predict the outcome of PKS systems. Further-
more, NP.searcher is open-source and can be freely mod-
ified through additional programming. We expect and
encourage additional PKS and NRPS modules to be incor-
porated in a collaborative community environment to
expand the scope and depth of this resource. NP.searcher
provides public access to 2D and 3D molecular structures
directly from DNA following input of nucleotide
sequence information and use of the resulting SMILES.
The user directly uploads the genome in FASTA format,
selects the predicted natural product cluster of interest,
and transfers the SMILES into any of a growing number of
chemical software programs (Figure 1). The chemical
structure output may also be useful in downstream molec-
ular property and bioactivity prediction.Page 2 of 10
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pathways with accessible DNA sequences from two well-
established databases: ASMPKS [15] for PKs and NORINE
[17] for primarily NRPs and mixed NRP/PK derived sys-
tems. To enhance our natural products search engine, we
also incorporated detection, though not structure genera-
tion, for trans-AT PKS systems as well as for terpenoids,
that represent new niches where many more useful natu-
ral products are likely to be discovered [18].
Implementation
Recognizing substrate specificity
The general overview of deciphering small molecules
from genomes is outlined below (Figure 2). Genomic data
in the form of DNA open reading frame text is translated
into amino acid sequences. PKS and NRPS gene clusters
are identified by searching for acyltransferase and ade-
nylation domains, respectively. Once these clusters are
identified, NP.searcher builds the molecule based on
stored specificity codes representing individual peptide or
polyketide subunits. This initial linear molecule is then
modified to produce a list of structures that may arise
from intramolecular reactions or tailoring of the metabo-
lite by additional enzymes found in the cluster.
NP.searcher distinguishes separate clusters by determin-
ing if the end of one activating domain is separated by
more than 15 kilobases from the beginning of another.
Separate clusters that specify three or more extension
The NP.searcher websiteFigure 1
The NP.searcher website. Upon the uploading of a genome, NP.searcher displays the predicted NRPS/PKS gene clusters 
and provides a summary of natural product systems found including those comprised of trans-AT as well as terpenoid genes. 
(B) Clicking on any of the clusters leads to SMILES of predicted molecules produced from the biosynthetic enzymes that can be 
transferred into chemical software such as Daylight Depict, Molinspiration, InChI, Smile23d, and ChemDraw. (C) Individual 
SMILES can be input into PubChem to search for existing molecules.Page 3 of 10
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read to output SMILES. NP.searcher uses Basic Local
Alignment and Search Tool (BLAST) to align sequences
with standard NRPS and PKS sequences and determine
the signature residues that predict substrate specificity
[19]. It also uses BLAST to recognize auxiliary domains
embedded within NRPS and PKS modules such as epimer-
ization, reduction, and methylation domains and
enzymes such as cytochrome P450s (Figure 3). Although
others have used HMM-specialized software to determine
specificity, some straightforward programming for auto-
mated analysis of the BLAST output produced an effective
method of extracting the signature residues and finding
the predicted substrate specificity.
NP.searcher runs BLAST once to match a generic NRPS/
PKS against an unknown NRPS/PKS. This enables align-
ment and extraction of the key residues of the unknown
NRPS or PKS. The program runs BLAST again to align the
discovered signatures with stored known signature
sequences to determine substrate specificity. This is a fast,
direct, and effective method of implementing BLAST to
determine substrate specificity without resorting to any
HMM-specific software. NP.searcher recognizes core and
auxiliary NRPS and PKS domains if they align with an
expectation value less than 0.1 and an identity greater
than 120. Once an acyltransferase or adenylation domain
of sufficient identity and length is recognized, the pro-
gram parses its sequence for the signature residues as iden-
tified previously for the NRPS and additional ones found
by compilation of various PKS sequences. We used a data-
base of 187 NRPS signature sequences of ten residues and
compiled PKS signature residues to build 18 PKS signa-
ture sequences of 18 residues from various published
reports [20-25]. The program compares the extracted
sequences and the database to reveal the substrate specif-
icity of the catalytic domains. If a particular signature
sequence is ambiguous regarding substrate selection, the
program employs an auxiliary prediction system using an
additive scoring algorithm to identify the most likely sub-
strate. If this fails because of inconclusive scoring, then the
NRPS or PKS residue is designated unknown and can be
seen as a generic peptide or polyketide subunit in the
structure.
Constructing the natural product
NP.searcher was written in the software language C++,
and modeled the assembly of NRPs and PKs as a linked
list. Upon recognition of the substrate specificity of a cat-
alytic domain, the SMILES string of the predicted chain
elongation intermediate is appended to the SMILES string
of the previous intermediate. During the elongation proc-
ess, polyketide or peptide monomers may be modified as
they are incorporated into the growing chain. Once the
construction of the core NRP or PK is completed, the
small molecule is modified based on a reaction list, where
cyclization and modifications specified by the user or
Conversion process from DNA to SMILESFigure 2
Conversion process from DNA to SMILES. DNA is 
converted to amino acid sequences, which is compared using 
BLAST to find clusters of catalytic domains from secondary 
metabolic pathways. These domains are further analyzed to 
find the signature sequences, or specificity codes. These 
codes are compared using BLAST with an internal database 
of signature sequences to determine the individual polyketide 
or peptide activated by each catalytic domain. The individual 
SMILES of these polyketides or peptides are concatenated to 
construct the basic linear molecule as a SMILES string. Addi-
tional SMILES are produced from modifications to this basic 
SMILES set.
Constructing and tailoring natural productsFigure 3
Constructing and tailoring natural products. Genome 
sequence data is translated and the NP.searcher uses BLAST 
to find NRPS and PKS gene clusters. BLAST is further used 
to find motifs of the adenylation and acyltransferase domains 
as well as auxiliary domains that function during chain assem-
bly to build the core molecule. BLAST is also used to identify 
enzymes involved in tailoring the molecule following core 
molecule assembly.Page 4 of 10
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encoded within the natural product cluster are applied.
The program computes every possible molecule given the
number of modifiable sites and the reactions designated.
All possible products computed by the program are added
to a product list, where they may be filtered by molecular
mass and included in the data output.
Results
The breadth of recognition
We examined 79 natural product gene clusters from the
databases NORINE and ASMPKS that produced metabo-
lites with accessible structural information. Nearly 60% of
PKS clusters and 80% of NRPS clusters were found to be
co-linear and modular, meaning that the molecule could
be constructed by transcription and translation of the
nucleic acid sequences in one direction. The program was
able to detect the twenty natural amino acids, twenty two
unnatural amino acids, and other chain elongation inter-
mediates in NRPS A domains and malonyl-CoA, methyl-
malonyl-CoA, ethylmalonyl-CoA, and methoxymalonyl-
CoA AT specificity in PKSs. Various functional groups of
amino acids and polyketide subunits contributed to the
diversity of chemical structures, and specified for example,
the dimerization of and disulfide bond formation within
certain molecules such as echinomycin (Figure 4). They
were also vital in forming the correct macrocyclized prod-
uct through serine in nostopeptolide and leucic acid in
cryptophycin (Figure 5).
Nucleophilic reactions such as heterocyclization hinted at
formation of familiar groups such as a thiazole in epothi-
lone [26,27] (Figure 5). Before performing heterocycliza-
tion reactions, there were seven structural predictions
based on the biosynthetic gene cluster for this myxobacte-
rial secondary metabolite. In three structural candidates
the thiol of cysteine was either involved in dimerization
or cyclization. In the other four candidate structures the
sulfhydryl group was free to form a thiazole with the
neighboring malonyl subunit. Performing heterocycliza-
tion on the molecules resulted in doubling of the four
candidate metabolites to produce another four containing
thiazole groups as opposed to malonyl and cysteinyl resi-
dues. After validating substrate specificity predictions on
254 adenylation domains from molecules in NORINE
and 333 acyltransferase domains from polyketide syn-
thases in ASMPKS, the accuracy of PKS acyltransferase
substrate prediction was ~93% while NRPS adenylation
substrate prediction was ~82% with ~77% of epimeriza-
tion domains detected (Tables 1 and 2). Substrate specifi-
city error was caused largely by unconventional starter
units that did not possess conserved signature sequences
stored in the database. We expect that this ambiguity will
be ameliorated by future addition of new signature
sequences to the database.
Uncertainties in prediction
Of the co-linear clusters, there was an average of 5.19 pre-
dicted molecules based on the ability of various func-
tional groups to enable macromolecular cyclization. The
PK-focused ASMPKS database elicited an average of 5.84
predictions per cluster while those of the NRP-focused
NORINE database had 4.64 predictions per cluster. This
difference is caused by the greater number of hydroxyl
groups on a PK that allow for cyclization. The core struc-
ture of the correctly predicted molecule differed in cases
where detected domains were silent or inactive, or
because of post-assembly tailoring modifications that
were not incorporated by the program. Silent and inactive
auxiliary PKS domains generated false positives, with 17%
of DH, 12% of ER, and 6.8% of KR recognized even
though they were inactive or silent based on the known
structure of the molecule (Table 3). The best predictions
aligned reasonably well with most of the actual structures
(Figure 5). With greater understanding of the HMM inher-
ent in the amino acid sequences that identify non-func-
tional catalytic domains and those that define the
presence and type of cyclization, our program will
become more accurate, flexible and predictive.
Various modifications could be performed on the linear
molecule predicted from the DNA sequence. NP.searcher
immediately generates a macrocyclized version of the
molecule upon determining the linear sequence. Oxygen,
nitrogen, and sulfur methylation can be applied to the
natural product pre- and post-assembly of the NRPs or
PKs derived core structure. NP.searcher allows epimeriza-
tion, carbon methylation, and three types of PKS process-
ing (DH, ER, KR) only during assembly with
halogenation, hydroxylation, heterocyclization, and glyc-
osylation only during post-assembly modifications. Thus,
there are eight assembly reactions, seven post-assembly
tailoring reactions, and two termination strategies
depending upon off-loading of a linear product or macro-
cyclization. Upon assembly and post-assembly modifica-
tions, NP.searcher outputs molecules as SMILES. Both
simple and highly complex structures can be displayed
through this text format, which is recognized by various
software in common use such as ChemDraw, Daylight
Depict, Molinspiration, Smile23d, InChI, and PubChem.
Additional functions
In addition to assembling and predicting modular NRPS/
PKS systems, the program is able to recognize trans-AT
PKS and terpenoid gene clusters. The substrate sequence
of trans-AT PKSs, unlike that of modular PKS derived AT
domains is apparently determined by ketosynthases
instead of acyltransferases [18]. Currently, the program
can detect, though not build, a trans-AT PK molecule. This
is accomplished by searching for consecutive KSs sepa-
rated by less than 15 kilobases without intervening ATs.Page 5 of 10
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searching for essential genes of the mevalonate and non-
mevalonate pathways: ispH and mvd1, respectively [28].
The innate ability of the program to perform post-assem-
bly tailoring reactions allows users to enrich the database
with additional core structure modifying enzymes. For
example, incorporating cytochrome P450s and their cor-
responding hydroxylation and epoxidation reactions
along with many other enzymes involved in natural prod-
uct structure diversification is the next step for expanding
the search engine's capabilities.
Discussion
The next frontier in drug discovery
In aiding investigators to discover secondary metabolites
by structure prediction, this new natural products search
engine enables drug discovery efforts to move one step
closer to prediction of molecules for lead optimization.
The development of SMILES analysis for biological activ-
ity coupled with the advancement of docking software
that can accept SMILES as input and dock them with pro-
teins opens the door to a useful new tool for pharmaceu-
tical research and development. Building in silico models
of newly discovered natural products to predict activity
and perform docking is another incremental step beyond
the trial-and-error method of drug development. The pre-
dicted natural products in SMILES format can be used to
generate both 2D and 3D representations in assorted
chemical software. 3D models produced from SMILES can
be used for docking with proteins using well-established
methods [29].
Challenges to prediction
Currently, the best predicted structure of the molecule dif-
fers significantly in many cases from the actual molecule
because of non-functional domains and unrecognized
post-tailoring modifications. Thus, small molecule-target
docking of the best predicted structure may not be repre-
Several predictions from the echinomycin clusterFigu e 4
Several predictions from the echinomycin cluster. NP. searcher generated seven SMILES from the echinomycin cluster 
based on different cyclization modes and the presence or absence of dimerization and disulfide linkages. The highlighted blue 
molecule is the core of the actual structure.Page 6 of 10
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Comparisons between predicted and actual structuresFigure 5
Comparisons between predicted and actual structures. The left column depicts the actual structures of molecules as 
verified chemically while the right column depicts the closest prediction from NP.searcher. Most unknown polyketide or pep-
tide units, as seen in the cryptophycin example, result from novel signature sequences that do not match well with any specifi-
city codes from our database of specificity codes compiled from literature sources. The actual chemical moieties are color-
coded blue while the predicted or unrecognized moieties are shown in red.
BMC Bioinformatics 2009, 10:185 http://www.biomedcentral.com/1471-2105/10/185sentative of the actual molecular interaction. However,
this is expected to improve with the deciphering of the
determinants of inactive or silent auxiliary domains,
along with further understanding of signature residues
that determine the absence or presence of cyclization, the
nature of cyclization, the type of post-assembly tailoring
modifications, and their sites of action.
Important limitations remain in this initial version of
NP.searcher and represent challenges for the future in this
open source tool. For example, an incomplete ability to
predict rare substrates because of a limited database of
known natural product starter and extender units can lead
to false or deficient predictions. However, finding com-
pounds with unknown groups during genome mining
might motivate the pursuit of predicted molecules as is
the case with cryptophycin. These predictions were made
from only a small number of known sequences and signa-
tures stored by NP.searcher. Adding the signature
sequences of these unique substrates to the search engine
would reduce significantly the number of unknown subu-
nits and increase program performance.
New sources for mining
The emerging views from marine invertebrate (e.g.
sponges, tunicates, ascidians) and terrestrial microbial
symbionts reveals that trans-AT PKS systems specify syn-
thesis of a large proportion of novel natural products, and
thus it is crucial to be able to genome-mine potential
products from these non-traditional clusters [18]. Further-
more, plant genomes should reveal a cornucopia of unex-
plored and diverse NRPs, PKs, and terpenoids that have
potential therapeutic applications [30]. With the develop-
ment of heterologous expression of plant secondary
metabolite pathways and better understanding of plant
natural product metabolic systems, these organisms
should increasingly become an attractive source of valua-
ble compounds [31,32]. Though terpenoid biosynthetic
mechanisms are yet to be elucidated as well as that of
NRPSs and PKSs, the abundance of medicines that may be
produced from them and the scientific curiosity in plant
biosynthesis might drive both industry and academia to
tackle terpenoid pathways more aggressively in the future
[33].
The keys to automated elucidation
With genome sequencing rapidly becoming more afford-
able, the bottleneck becomes the ever-elusive ability to
predict small molecule structure, and more challengingly,
protein three-dimensional structures from two-dimen-
sional specifications. Although, there are sure to be an
enormous number of novel enzymes to discover and char-
acterize functionally, the existing database of known pro-
teins and increasingly refined biochemical tools such as
metabolic and gene expression profiling coupled with
heterologous protein expression will accelerate solving
enzymatic puzzles [34]. Enzymes with low substrate spe-
cificity may be difficult to analyze using hidden Markov
models and the time to use them in silico may not come
until we can accurately simulate protein dynamics.
With better understanding of how natural products are
genetically and enzymatically determined and the
advance of rapid genomic scanning technologies, there is
a need to extract chemical knowledge from genetic infor-
mation more efficiently for potential applications. Taking
advantage of the recent advances in natural products
domain recognition, NP.searcher decodes natural product
gene clusters into molecules and brings to the forefront
the ability to recognize thousands of new secondary
metabolites. On the more basic level, this program can
function as an editing device to compose natural product
Table 1: Validation of PKS domain recognition
Co-linear/Non-co-linear Genes ATa KRb DHc ERd
Ratio 23/39 309/333 291/293 159/177 59/60
Percentage (%) 59.0 92.8 99.3 89.8 98.3
a AT, acyltransferase. b KR, ketoreductase. c DH, dehydrogenase. d ER, enoylreductase.
Highly unique PKS sequences that did not align with database-derived PKS AT, KR, DH, and ER sequences using BLAST resulted in some false 
negatives.
Table 2: Validation of NRPS domain recognition
Co-linear/Non-co-linear Genes Aa/Total # of A domains Eb domains detected/Total # of E domains
Ratio 32/40 208/254 30/39
Percentage (%) 80.0 81.9 76.9
a A, adenylation. b E, epimerization.
Highly unique NRPS sequences that did not align with database-derived NRPS A and E sequences using BLAST resulted in some false negatives.Page 8 of 10
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neering capabilities, this program will enable biologists
and chemists to envision possible NRPs and PKs to design
de novo pathways by metabolic engineering or synthetic
biology approaches. At the most advanced and useful
level, NP.searcher may read through thousands of gene
clusters and automatically construct and screen potential
natural product molecules from large databases of
uncharacterized microbial genome or mixed metagenome
sequences. In another future application, the develop-
ment of better protein three-dimensional modeling, the
program will seek to employ reverse engineering to pro-
vide DNA sequences required to prescribe the biosynthe-
sis of a particular natural product molecule.
A natural products search engine
In addition to extensively searching through chemical
space, NP.searcher performed intramolecular reactions in
output structures as seen with echinomycin. Such
dynamic in silico enzymology will be necessary to eluci-
date compounds with the complexity of the NRPS-derived
antibiotic vancomycin [35]. Given the diverse chemical
arsenal found in Nature, such an extensive search capabil-
ity promises to uncover interesting candidate metabolites
from NP.searcher by performing various intramolecular
reactions on a natural product molecule. Moreover, the
SMILES output of the program can be applied to other
software to analyze and predict biological activities rele-
vant to selected drug targets. In addition to the challenges
of predicting bioactivity from SMILES, resulting 2D and
3D structures, and predicting cytotoxicity and drug action
for a predicted structure, other important challenges
remain to be addressed such as elucidation of terpene bio-
synthesis and non-co-linear and dispersed synthetase sys-
tems in microbes and plants. Accordingly, the broad
potential of cost-efficient genome sequencing coupled to
rapid and accurate prediction of secondary metabolic
products and biological activity provides an urgent moti-
vation to accomplish these objectives more quickly and
effectively.
Conclusion
NP.searcher was developed to scan rapidly microbial
genomes for secondary metabolite biosynthetic gene clus-
ters, and output candidate nonribosomal peptide and
polyketide natural products in SMILES format, enabling
immediate decoding of DNA to produce 2D and 3D struc-
tures in widely available software. The ability to recognize
novel NRP and PK products will grow with continuous
updating of the search engine's database of adenylation
and acyltransferase signature sequences for various amino
acid and polyketide starter and extender units. The value
of NP.searcher is likely to improve with addition of algo-
rithms built on further proteomic analysis that reveal the
basis for post-assembly tailoring steps such as cyclization,
glycosylation, methylation, and various other common
reactions, further enhancing the output of structural pre-
dictions. With the development of faster and cheaper
genome sequencing technologies, NP.searcher may be
increasingly useful in the rapid screening of suitable natu-
ral product drug candidates directly from genomic infor-
mation.
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